Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
$975M |
| 2 |
Amazon
AMZN
|
$708M |
| 3 |
UnitedHealth
UNH
|
$634M |
| 4 |
Rivian
RIVN
|
$504M |
| 5 |
TJX Companies
TJX
|
$483M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$1.1B |
| 2 |
NVIDIA
NVDA
|
$814M |
| 3 |
L3Harris
LHX
|
$714M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
$503M |
| 5 |
Texas Instruments
TXN
|
$468M |
Sector Composition
| 1 | Technology | 32.52% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Financials | 9.67% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
MSCI
MSCI
$43.4B
| $180M | 0.08% |
293,759
-30,030
| -9% | -$18.4M |
|
252
Brady Corp
BRC
$3.77B
| $179M | 0.07% |
3,329,778
+4,712
| +0.1% | +$254K |
|
253
Bio-Techne
TECH
$8.36B
| $179M | 0.07% |
1,384,932
+20,476
| +2% | +$2.65M |
|
254
CDW
CDW
$22.1B
| $179M | 0.07% |
871,833
-123,058
| -12% | -$25.2M |
|
255
Constellium
CSTM
$2B
| $178M | 0.07% |
9,943,448
-153,524
| -2% | -$2.75M |
|
256
Envista
NVST
$3.51B
| $177M | 0.07% |
3,934,723
+510,272
| +15% | +$23M |
|
257
Teradyne
TER
$19.2B
| $177M | 0.07% |
1,081,670
+289,567
| +37% | +$47.4M |
|
258
Willis Towers Watson
WTW
$32.2B
| $175M | 0.07% |
736,075
+505,603
| +219% | +$120M |
|
259
Insulet
PODD
$24.4B
| $175M | 0.07% |
656,523
-197,230
| -23% | -$52.5M |
|
260
Automatic Data Processing
ADP
$120B
| $173M | 0.07% |
702,635
+30,916
| +5% | +$7.62M |
|
|
OCDX
261
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $173M | 0.07% |
8,068,533
-169,553
| -2% | -$3.63M |
|
262
Hartford Financial Services
HIG
$36.8B
| $172M | 0.07% |
2,484,314
+554,465
| +29% | +$38.3M |
|
263
Goldman Sachs
GS
$223B
| $171M | 0.07% |
445,918
+80,431
| +22% | +$30.8M |
|
264
OSI Systems
OSIS
$3.9B
| $170M | 0.07% |
1,823,798
+15,143
| +0.8% | +$1.41M |
|
265
Capital One
COF
$140B
| $168M | 0.07% |
1,155,974
+147,108
| +15% | +$21.3M |
|
|
ENV
266
DELISTED
ENVESTNET, INC.
ENV
| $168M | 0.07% |
2,113,868
-81,822
| -4% | -$6.49M |
|
|
ARNA
267
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $167M | 0.07% |
1,798,634
+561,482
| +45% | +$52.2M |
|
268
Core & Main
CNM
$12.6B
| $161M | 0.07% |
5,319,367
-53,944
| -1% | -$1.64M |
|
|
GBT
269
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $160M | 0.07% |
5,483,164
-789,518
| -13% | -$23.1M |
|
270
Sempra
SRE
$52.1B
| $156M | 0.07% |
2,357,802
-18,710
| -0.8% | -$1.24M |
|
271
PTC Therapeutics
PTCT
$4.51B
| $155M | 0.06% |
3,901,397
+326,210
| +9% | +$13M |
|
272
Sun Communities
SUI
$16.2B
| $154M | 0.06% |
735,412
+27,225
| +4% | +$5.72M |
|
273
ITT
ITT
$13.5B
| $154M | 0.06% |
1,504,535
-143,897
| -9% | -$14.7M |
|
274
Clarivate
CLVT
$2.96B
| $154M | 0.06% |
6,537,173
+1,154,169
| +21% | +$27.1M |
|
275
Interpublic Group of Companies
IPG
$9.85B
| $153M | 0.06% |
4,080,473
+693,496
| +20% | +$26M |
|